Publications

BibTex format

@article{Seedat:2018:10.1016/S1473-3099(18)30117-8,
author = {Seedat, F and Hargreaves, S and Nellums, LB and Ouyang, J and Brown, M and Friedland, JS},
doi = {10.1016/S1473-3099(18)30117-8},
journal = {Lancet Infectious Diseases},
pages = {e259--e271},
title = {How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review},
url = {http://dx.doi.org/10.1016/S1473-3099(18)30117-8},
volume = {18},
year = {2018}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Rates of migration to Europe, and within Europe, have increased in recent years, with considerable implications for health systems. Migrants in Europe face a disproportionate burden of tuberculosis, HIV, and hepatitis B and C, yet experience a large number of barriers to accessing statutory health care on arrival. A better understanding of how to deliver effective and cost-effective screening, vaccination, and health services to this group is now crucial. We did a systematic review to document and assess the effectiveness and cost-effectiveness of approaches used for infectious diseases screening, and to explore facilitators and barriers experienced by migrants to accessing screening programmes. Following PRISMA guidelines, we searched Embase, PubMed, PsychINFO, the Cochrane Library, and Web of Science (1989 to July 1, 2015, updated on Jan 1, 2018), with no language restrictions, and systematically approached experts across the European Union (EU) for grey literature. Inclusion criteria were primary research studies assessing screening interventions for any infectious disease in the migrant (foreign-born) population residing in EU or European Economic Area (EEA) countries. Primary outcomes were the following effectiveness indicators: uptake of screening, coverage, infections detected, and treatment outcomes. Of 4112 unique records, 47 studies met our inclusion criteria, from ten European countries (Belgium, Denmark, France, Italy, the Netherlands, Norway, Spain, Sweden, Switzerland, and the UK) encompassing 248402 migrants. We found that most European countries screening migrants focus on single diseases only-predominantly active or latent tuberculosis infection-and specifically target asylum seekers and refugees, with 22 studies reporting on other infections (including HIV and hepatitis B and C). An infection was detected in 3·74% (range 0·00-95·16) of migrants. Latent tuberculosis had the highest prevalence across all infections (median 15&mi
AU  - Seedat,F
AU  - Hargreaves,S
AU  - Nellums,LB
AU  - Ouyang,J
AU  - Brown,M
AU  - Friedland,JS
DO  - 10.1016/S1473-3099(18)30117-8
EP  - 271
PY  - 2018///
SN  - 1473-3099
SP  - 259
TI  - How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review
T2  - Lancet Infectious Diseases
UR  - http://dx.doi.org/10.1016/S1473-3099(18)30117-8
UR  - https://www.ncbi.nlm.nih.gov/pubmed/29778396
UR  - http://hdl.handle.net/10044/1/59669
VL  - 18
ER  -

Download

ProfessorJonFriedland

Contact

Assistant

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)